CEA-Leti’s New Imaging System for fDOT Ready for Commercialization, Use in Measuring and Treating Cancer

GRENOBLE, France--(BUSINESS WIRE)--CEA-Leti today announced that after extensive beta testing at five French research facilities, its new imaging system for near-infrared fluorescence-enhanced diffuse optical tomography (fDOT) is ready for commercial applications.
MORE ON THIS TOPIC